Comments
The ₹25-crore rights issue of Krebs Biochemicals & Industries will open for subscription on Wednesday and end on March 15. The company is offering 21 shares for every 100 held to its existing shareholders at ₹75 share. Krebs Biochemicals had set February 1 as the record date to identify eligible shareholders for the rights issue. The stock will remain in focus, as it closed at ₹87 on the NSE. At the end of December 2018, 4,706 small retail invesotrs hold 11.31 per cent stake.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.